DNA Methylation Sequencing Market

DNA methylation is an important component of epigenetics and plays an important role in maintaining normal cell function, genetic imprinting, embryonic development, and human tumorigenesis. Whole Genome Bisulfite Sequencing (WGBS), which treats genomic DNA with bisulfite to convert unmethylated cytosine C to uracil U, and performs whole-genome weighting on the treated DNA Sequencing and comparison with the reference genome to achieve single-base resolution and high-accuracy methylation level analysis from the genome level, widely used in basic mechanisms such as cell differentiation, tissue development, animal and plant breeding, human health And research fields such as disease treatment.
DNA Methylation Sequencing Market contains market size and forecasts of DNA Methylation Sequencing in Global, including the following market information:
Global DNA Methylation Sequencing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global DNA Methylation Sequencing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Whole Genome Bisulfite Sequencing (WGBS) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of DNA Methylation Sequencing include Berry Genomics, Illumina Inc., Diagenode, Novogene, Qiagen N.V., Oebiotech, Biomarker, Sigma Aldrich Corporation and BGI, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the DNA Methylation Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global DNA Methylation Sequencing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global DNA Methylation Sequencing Market Segment Percentages, by Type, 2021 (%)

• Whole Genome Bisulfite Sequencing (WGBS)
• Reduced Representation Bisulfite Sequencing (RRBS)
• MeDIP-Sequncing

Global DNA Methylation Sequencing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global DNA Methylation Sequencing Market Segment Percentages, by Application, 2021 (%)

• Epigenetic Research
• Massive Clinical Sample Studies

Global DNA Methylation Sequencing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global DNA Methylation Sequencing Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies DNA Methylation Sequencing revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies DNA Methylation Sequencing revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Berry Genomics
• Illumina Inc.
• Diagenode
• Novogene
• Qiagen N.V.
• Oebiotech
• Biomarker
• Sigma Aldrich Corporation
• BGI
• F. Hoffmann-La Roche Ltd.
• Zymo Research Corporation